The role of immune cells infiltrating the kidney in the pathogenesis of salt-sensitive hypertension

Journal of Hypertension

Volumn 20, Issue SUPPL. 3, 2002, Pages

  Rodríguez Iturbe, Bernardo ^a   Quiroz, Yasmir ^a   Herrera Acosta, Jaime ^a   Johnson, Richard J ^a   Pons, Héctor A ^a  

^a NONE   (Venezuela)

Author keywords

Angiotensin II; Hypertension; Immune system; Superoxide positive cells

Indexed keywords

ANGIOTENSIN; NITRIC OXIDE; SODIUM; DRUG DERIVATIVE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SODIUM CHLORIDE;

ANIMAL MODEL; BLOOD PRESSURE; CELL INFILTRATION; CONFERENCE PAPER; HYPERTENSION; IMMUNOCOMPETENT CELL; LYMPHOCYTE; MACROPHAGE; NATRIURESIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SALT INTAKE; SODIUM ABSORPTION; SPONTANEOUSLY HYPERTENSIVE RAT; ANIMAL; HUMAN; IMMUNOLOGY; KIDNEY; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; HUMANS; HYPERTENSION; KIDNEY; LYMPHOCYTES; MYCOPHENOLIC ACID; SODIUM CHLORIDE;

EID: 0036600416     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200212000-00001     Document Type: Conference Paper

References (65)

1. Evidence for an initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice
2. Arterial pressure regulation. Overriding dominance of the kidney in long-term regulation and in hypertension
3. The role of the kidney in hypertension
4. Abnormal pressure natriuresis: A cause or consequence of hypertension?
5. Regulation of sodium balance in hypertension
6. Renal interstitial hydrostatic pressure and pressure natriuresis in pregnant rats
7. Thymus dependency of periarteritis nodosa in DOCA and salt-treated mice
8. Spontaneous hypertensive and hypertensive vascular disease in the NZB strain of mice
9. Antihypertensive effect of an immunosuppressive agent, cyclophosphamide, in genetically hypertensive rats of the Lyon strain
10. Immune system modulation and its effect on blood pressure of the spontaneously hypertensive male and female rat
11. Thymectomy delays the development of hypertension in Okamoto spontaneously hypertensive rats
12. Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts
13. Immune system dysfunction contributes to the aetiology of spontaneously hypertension
14. The immune system and hypertension
15. Do immune system changes have a role in hypertension?
16. Associations between disturbances of the immune system and hypertension
17. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure
18. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition
19. Role of immunocompetent cells in nonimmune renal diseases
20. Reduction of immune cells infiltrating the kidney results in lowering of the blood pressure in genetically hypertensive rats
21. The importance of the kidney in primary hypertension: Insights from cross-transplantation
22. Salt-sensitive hypertension develops after short-term exposure to angiotensin II
23. Renal injury and salt-sensitive hypertension after exposure to catecholamines
24. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage
25. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension
26. Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthesis inhibition
27. The vicious circle in chronic Bright's disease: Experimental evidence
28. Early interstitial changes in hypertension-induced renal injury
29. Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension
30. Elevated uric acid increases blood pressure in the rat by a novel crystal independent mechanism
31. On the mechanism of the effects of potassium restriction on blood pressure and renal sodium retention
32. Chronic potassium depletion induces renal injury, salt-sensitivity and hypertension in young rats
33. Protein overload (PO) proteinuria is followed by salt-sensitive hypertension (SSHTA) that can be prevented with suppression of the protein-induced immune infiltration of the kidney
34. Subclinical renal injury induced by cyclosporine exposure is associated with salt-sensitive hypertension
35. Alterations of renal function during dietary-induced hyperuricemia in the rat
36. Interstitial nephritis induced by protein-overload proteinuria
37. Heterogeneity in the appearance and distribution of macrophage subsets and their possible involvement in hypertensive vascular lesions in rats
38. Alterations of nitric oxide synthase expression with aging and hypertension in rats
39. Mycophenolate mofetil and its mechanism of action
40. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats
41. Effect of mycophenolate mofetil on TNF alpha-induced expression of cell adhesion molecules in human venous endothelial cells in vitro
42. Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbit
43. Mycophenolate mofetil reduces myofibroblast infiltration and collagen II deposition in rat remnant kidney
44. Mycophenolate mofetil reduces renal injury in the chronic synthase inhibition model
45. Angiotensin II (AII) infusion is associated with overexpression of vimetin and heat shock protein (HSP) 60 and tubulointerstitial infiltration of γδ lymphocytes
46. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney
47. Combining an antiproteinuric approach with mycophenolate mofetil suppresses progressive nephropathy of experimental animals
48. Antihypertensive effect of thymectomy in Lyon hypertensive rat. Vascular reactivity, renal histology and sodium excretion
49. Angiotensin II increases MCP-1 and activates NF-κB and AP-1 in cultured mesengial and mononuclear cells
50. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis
51. The renal origin of hypertension
52. Differential regulation of renal glomerular and preglomerular vascular angiotensin II receptors
53. Regulation of type 1 angiotensin II receptor and its subtype gene expression in kidney by sodium loading and angiotensin II infusion
54. Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule
55. Regulation of angiotensin II type-1 receptor mRNA and protein in angiotensin II-induced hypertension
56. Inflammation and tissue injury: The world of free radicals
57. Oxidative stress in the Dahl hypertensive rat
58. Plasma hydrogen peroxide in hypertensives and normotensive subjects at genetic risk of hypertension
59. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation
60. Renal injury from angiotensin II-mediated hypertension
61. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis
62. Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin
63. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis
64. Experimental studies on the role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in hypertensive nephrosderosis
65. Effects of early and late antihypertensive treatment on extracellular matrix proteins and mononuclear cells in uninephrectomized SHR